Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000355538 | SCV000345041 | uncertain significance | not provided | 2016-09-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000793836 | SCV000933212 | uncertain significance | Bardet-Biedl syndrome | 2022-10-05 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 291 of the TRIM32 protein (p.Ile291Met). This variant is present in population databases (rs766687896, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with TRIM32-related conditions. ClinVar contains an entry for this variant (Variation ID: 290478). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001334687 | SCV001527600 | uncertain significance | Bardet-Biedl syndrome 11 | 2018-03-01 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Fulgent Genetics, |
RCV002487282 | SCV002793333 | uncertain significance | Sarcotubular myopathy; Bardet-Biedl syndrome 11 | 2021-12-01 | criteria provided, single submitter | clinical testing |